Based in LAS VEGAS, NV, HEMOSTASIS AND THROMBOSIS CENTER OF NEVADA operates as a Public Charity. The organization reported $29.0M in revenue, $24.4M in expenses, $15.4M in total assets for fiscal year 2025. Imperigo tracks 25 reported grant relationships connected to this organization totaling approximately $719K.
THE PRIMARY PURPOSE OF THE ORGANIZATION IS TO PROVIDE COMPREHENSIVE CLINICAL CARE TO PERSONS AFFECTED BY INHERITED BLOOD DISORDERS AND TO ADMINISTER PROGRAMS SUPPORTED BY FEDERAL GRANTS AWARDED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES HEALTH RESOURCES SERVICES ADMINISTRATION (HRSA) AND BY THE CENTERS OF DISEASE CONTROL (CDC), INCLUDING GRANTS RELATED TO HEMOPHILIA AND SICKLE CELL DISEASE.
How Hemostasis and Thrombosis Center of Nevada divides every $100 it spends, from its own Form 990 filings, averaged across 7 years.
No fundraising costs are reported. That often means fundraising runs through a separate affiliated organization that files its own return.
Source: Form 990 filings with the IRS, latest fiscal year 2025. Shares are from the organization's reported expenses. Data by Imperigo; not affiliated with the IRS.
Showing up to 5 of 25 total records — full history available with membership.
Officer compensation and complete director data available with membership.
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2025 | $29.0M | $24.4M | $15.4M |
| 2024 | $24.1M | $23.3M | $10.4M |
| 2023 | $24.0M | $23.2M | $9.9M |
| 2021 | $21.0M | $19.1M | $7.5M |
| 2020 | $13.7M | $12.7M | $4.5M |
Between 2020 and 2025, reported annual revenue grew from $13.7M to $29.0M (+111%), with total assets most recently reported at $15.4M.
Interactive year-over-year charts and full filing details available with membership.
